Form 4: Xingjuan Chao Acquires Ceribell Stock and Options

Xingjuan Chao, President and CEO of Ceribell, Inc., acquired 97,555 shares of common stock and was granted an option to purchase 162,592 shares.

Summary

• Xingjuan Chao, President and CEO of Ceribell, Inc., acquired 97,555 shares of common stock on April 1, 2026, with no cost associated with this acquisition.
• Additionally, Chao was granted a stock option to purchase 162,592 shares of common stock at an exercise price of $18.50 per share, with an expiration date of April 1, 2036.
• The shares subject to the stock option are set to vest on a quarterly basis starting May 20, 2026, contingent upon continued employment.
• Chao also holds indirect beneficial ownership of 369,088 shares through the ACP 2021 Trust, of which she is a co-trustee.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it reflects standard executive compensation practices and insider activity, indicating continued management engagement without immediate financial implications for the company.

Positives

• Acquisition of a significant number of common shares by a key executive.
• Grant of stock options to the President and CEO, aligning executive incentives with company performance.
• The stock option grant has a long expiration date, indicating a long-term commitment.
• Vesting schedule for stock options encourages continued employment and service.

Negatives

• The filing does not provide details on the rationale behind the stock acquisition or option grant, such as performance-based awards or compensation adjustments.
• The exercise price of the stock option ($18.50) is noted, but its relation to the current market price is not provided in this filing.

Risks

• The vesting of stock options is contingent upon continued employment, meaning a departure from the company would result in forfeiture of unvested options.
• The value of the stock options is subject to market fluctuations and the future performance of Ceribell, Inc.

Future Outlook

The stock options granted to Xingjuan Chao are exercisable and vest over time, indicating a forward-looking incentive tied to her continued service and the company's future performance.

Management Comments

• The Reporting Person disclaims beneficial ownership of securities held by the ACP 2021 Trust except to the extent of her pecuniary interest therein.
• The shares subject to the option shall vest on each quarterly anniversary from May 20, 2026, subject to the Reporting Person's continued employment service relationship with the Issuer on each such vesting date.

Industry Context

StockSavvy.ai notes that insider transactions, such as stock acquisitions and option grants to key executives like the President and CEO, are common in the biotechnology and medical device sectors as a means to attract, retain, and incentivize top talent. These actions often signal management's confidence in the company's long-term prospects.

Related Party Transactions

• Xingjuan Chao is a co-trustee of the ACP 2021 Trust, which holds 369,088 shares of Ceribell, Inc. common stock. She disclaims beneficial ownership of these shares except to the extent of her pecuniary interest.

Stakeholder Impact

• Shareholders: The acquisition of stock by the CEO may be interpreted as a positive signal of confidence in the company's future. The stock option grant aligns executive interests with shareholder value creation.
• Employees: The vesting schedule for the stock options encourages continued employment and dedication from the CEO.
• Management: The transaction reflects standard executive compensation and incentive structures.

Next Steps

• Xingjuan Chao may exercise her stock options according to the vesting schedule.
• Continued monitoring of Ceribell, Inc.'s stock performance and executive compensation practices.

Key Dates

Keywords

Form 4, SEC Filing, Insider Trading, Stock Options, Restricted Stock Units, Beneficial Ownership, Ceribell Inc., CBLL, Xingjuan Chao, Executive Compensation